Market Place
Sourcing Support
Almirall Inaugurates Offices In China To Advance Innovation
12 Mar 2026 //
BUSSINESSWIRE
Almirall Releases 2025 Financial Results
23 Feb 2026 //
PHARMIWEB
Almirall Approves Seysara In China For Moderate-To-Severe Acne
30 Jan 2026 //
BUSINESSWIRE
Almirall Starts Lebrikizumab`s Phase 3 LumiNE in Nummular Eczema
15 Jan 2026 //
BUSINESSWIRE
Almirall Showcase R&D Progress In Dermatology At J.P. Morgan Conf
14 Jan 2026 //
BUSINESSWIRE
Almirall`s Immunoskin Conference Advances Inflammatory Skin
11 Nov 2025 //
PHARMIWEB
Almirall`s 2025 9M Results
10 Nov 2025 //
BUSINESS WIRE
Almirall Reveals Long-Term Psoriasis Treatment Results at EADV
18 Sep 2025 //
BUSINESSWIRE
Almirall H1 2025 Results
25 Jul 2025 //
BUSINESSWIRE
Almirall Q1 2025 Results
12 May 2025 //
BUSINESSWIRE
Biofrontera, Almirall Launch Hats On Challenge for Actinic Keratosis
01 May 2025 //
GLOBENEWSWIRE
Almirall hosts 16th Skin Academy for dermatology professionals
21 Mar 2025 //
BUSINESSWIRE
Almirall Presents AK Treatment, Tirbanibulin Data At AAD 2025
07 Mar 2025 //
BUSINESSWIRE
Almirall Names Jon U. Garay Alonso As CFO From Aug 2025
06 Mar 2025 //
BUSINESSWIRE
Almirall Exceeds 2024 Guidance, Advances Dermatology Pipeline
24 Feb 2025 //
BUSINESSWIRE
Almirall Enters New Era Of Growth At Morgan Healthcare Conference
14 Jan 2025 //
BUSINESSWIRE
Almirall Reports Q3 2024 Results Driven by Dermatology Portfolio
11 Nov 2024 //
BUSINESSWIRE
Almirall Completes Efinaconazole Approval Procedure In Europe
15 Oct 2024 //
BUSINESSWIRE
Almirall Reports 6.7% Net Sales Growth In H1 2024 Led By Dermatology
22 Jul 2024 //
BUSINESSWIRE
Almirall Launches Act4Impact Sustainability Strategy With 2030 Targets
02 Jul 2024 //
BUSINESSWIRE
FDA Approves Almirall`s Klisyri For Expanded Actinic Keratosis Treatment
10 Jun 2024 //
BUSINESSWIRE
Almirall’s Klisyri approved to treat larger actinic keratosis areas
10 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
Almirall `Stay Vigilant` Actinic Keratosis Awareness Campaign Launched
30 May 2024 //
FIERCE PHARMA
Almirall Q1 2024: 6.6% Growth, EU Derma +18%
13 May 2024 //
BUSINESSWIRE
Novo Licenses to Almirall Potential First-in-Class Antibody Candidate
20 Feb 2024 //
BIOSPACE
Almirall continues its progress to leadership in Medical Dermatology
19 Feb 2024 //
BUSINESSWIRE
Almirall partners with etherna
12 Dec 2023 //
ENDPTS
Almirall Receives European Commission Approval of EBGLYSS
17 Nov 2023 //
BUSINESSWIRE
Almirall and Absci announce AI drug discovery partnership
14 Nov 2023 //
BUSINESSWIRE
Almirall’s Nine-month 2023 Results:
09 Nov 2023 //
BUSINESSWIRE
Almirall signs $210M deal with EpimAb to develop bispecifics
12 Oct 2023 //
FIERCE BIOTECH
Centrient Pharmaceuticals joins Almirall’s growing innovation hub in Barcelona
10 Oct 2023 //
PRESS RELEASE
Almirall Upgrades Werum PAS-X MES
19 Sep 2023 //
CONTRACT PHARMA
Almirall Achieves Net Sales Growth of 7% to €466.1MM
24 Jul 2023 //
BUSINESSWIRE
Almirall makes dramatic mini-series to show life with psoriasis
27 Jun 2023 //
FIERCE PHARMA
Almirall launches Nina, the first series to highlight the major impact
20 Jun 2023 //
BUSINESSWIRE
Almirall announces the pricing of €200mm non pre-emptive share capital increase
13 Jun 2023 //
BUSINESSWIRE
Almirall Announces the Launch of a €200mm Non Pre-Emptive Share Capital Increase
12 Jun 2023 //
BUSINESSWIRE
Almirall finds 85% of patients are unaware of Klisyri indication
05 Jun 2023 //
FIERCE PHARMA
Almirall, The First to Assess Wellbeing in a Dermatology Clinical Study
12 Apr 2023 //
BUSINESSWIRE
ZeClinics Moves Headquarters to Almirall R&D Centre
27 Feb 2023 //
CONTRACT PHARMA
Spain`s Almirall expects core earnings to fall in 2023
20 Feb 2023 //
REUTERS
Almirall to Participate in the 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 //
BUSINESSWIRE
Almirall signs on with clinical trial project to collect data
29 Nov 2022 //
FIERCEBIOTECH
Almirall joins FACILITATE, a patient-driven IMI project
28 Nov 2022 //
BUSINESSWIRE
Almirall to take part in FACILITATE project to enable trial data usage
28 Nov 2022 //
CLINICALTRIALSARENA
Almirall sheds light on the mental effects of psoriasis
23 Nov 2022 //
FIERCEPHARMA
Almirall’s Nine-month 2022 Results
10 Nov 2022 //
BUSINESSWIRE
Spain`s Almirall Q3 core earnings fall 13%; keeps outlook
10 Nov 2022 //
REUTERS
Almirall PROSES shows acne treatment decreases burden of impact on sufferers
21 Oct 2022 //
BUSINESSWIRE
Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc
30 Sep 2022 //
PRESS RELEASE
Almirall`s Klisyri receives strong recommendation in AAD AK guideline update
18 Aug 2022 //
PRNEWSWIRE
Almirall achieves Core Net Sales growth of 5.1% to 436.6 MM Euros in H1
25 Jul 2022 //
PRNEWSWIRE
Almirall launches new call to find innovative therapies for skin diseases
21 Jul 2022 //
PHARMIWEB
Almirall-backed psoriasis support app Claro launches in Europe
14 Jun 2022 //
PHARMAPHORUM
Happify Health and Almirall Go Live with Digital Solution
13 Jun 2022 //
BUSINESSWIRE
Almirall: `Listen to what your marks whisper to you`
26 May 2022 //
FIERCEPHARMA
Almirall rolls out sales rep AI system, cutting pre-call prep
26 May 2022 //
ENDPTS
Dermatology Pact Latest to Showcase Broad Potential of Evotec`s Platform
19 May 2022 //
BIOSPACE
Almirall delivers good business performance in Q1
09 May 2022 //
PRNEWSWIRE
